Filing Flows › Eastman Chemical (EMN) › Q2 2026 › vs Q2 2025
Eastman Chemical (EMN) Q2 2026 vs Q2 2025 (year over year)
Eastman Chemical's revenue rose $226M (+10%) from $2.3B in Q2 2025 to $2.5B in Q2 2026. Gross margin 22.3% against 22.1% (+0.2 pts).
Eastman Chemical, Q2 2026: revenue $2.5B (+10% year over year), operating margin 10.2%, net earnings $184M, operating cash flow $224M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 22.3% | 22.1% | +0.2 pts |
| Operating margin | 10.2% | 7.4% | +2.8 pts |
| Net margin | 7.3% | 6.1% | +1.2 pts |
| Free cash flow margin | 4.9% | 3.6% | +1.3 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.5B | $2.3B | $226M | +10% |
| Gross profit | $560M | $506M | $54.0M | +11% |
| Cost of revenue | $2.0B | $1.8B | $172M | +10% |
| Operating profit | $256M | $169M | $87.0M | +51% |
| Operating expenses | $304M | $337M | −$33.0M | -10% |
| Pre-tax earnings | $256M | $169M | $87.0M | +51% |
| Research & development | $65.0M | $67.0M | −$2.0M | -3% |
| SG&A | $185M | $157M | $28.0M | +18% |
| Other operating costs | $54.0M | $113M | −$59.0M | -52% |
| Net earnings | $184M | $140M | $44.0M | +31% |
| Income tax | $72.0M | $29.0M | $43.0M | +148% |
| Depreciation & amortization | $132M | $127M | $5.0M | +4% |
| Share-based compensation | $19.0M | $2.0M | $17.0M | +850% |
| Working capital & other | $111M | $36.0M | $75.0M | +208% |
| Operating cash flow | $224M | $233M | −$9.0M | -4% |
| Free cash flow (OCF − capex) | $124M | $83.0M | $41.0M | +49% |
| Capital expenditures | $100M | $150M | −$50.0M | -33% |
Questions
How much did Eastman Chemical's revenue grow year over year in Q2 2026?
Eastman Chemical's revenue rose $226M (+10%) from $2.3B in Q2 2025 to $2.5B in Q2 2026. Gross margin 22.3% against 22.1% (+0.2 pts).